Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced positive 24-month results from the pivotal U.S.

Shares of Bausch + Lomb rose in premarket trading Monday after the company said that data from its glaucoma procedure trials was positive. Shares in New York traded 5% higher ahead of the morning bell ...

Introduction: Glaucoma is a major cause of irreversible blindness, with particularly high prevalence and aggressiveness in ...

The Conversation reports cataract surgery is safe and common, with over 90% achieving 20/20 vision, but patients need to ...

US News evaluated freestanding ASCs only, excluding hospital-affiliated outpatient departments to avoid overlap with hospital ...

Glaucoma is one of the most common causes of permanent blindness in the world. It slowly damages the optic nerve, which is ...

A landmark glaucoma surgery was performed at the Army Hospital using the Hydrus Microstent guided by intraoperative aqueous angiography. This technique enhances drainage in glaucoma patients, marking ...

Glaucoma is likely to be treated when IOP reaches 22 mm Hg, but research shows that risk consistently increases even at lower ...

Explore the latest research on glaucoma treatment and the role of immune cells in eye pressure regulation for better outcomes ...

This is likely due to untreated myopia in these earlier generations of Singaporeans, who did not have many treatment options in their growing-up years.

People who undergo incisional surgery for glaucoma and live in areas with elevated levels of oxidative air pollution may be more likely to have the procedure fail than patients who live in areas with ...

President Donald Trump's border czar Tom Homan announced Thursday that the administration will conclude Operation Metro Surge in Minnesota. Homan told reporters during a news conference at the Bishop ...